Akebia Therapeutics (AKBA) Amortizatization of Intangibles (2014 - 2024)

Akebia Therapeutics (AKBA) has 11 years of Amortizatization of Intangibles data on file, last reported at $9.0 million in Q4 2024.

• Amortizatization of Intangibles for Q4 2024 came in at $9.0 million, changed 0.36% year-over-year; the trailing twelve-month figure through Sep 2025 was $9.0 million (down 74.89% YoY), and the FY2024 annual result was $36.0 million, changed 0.0% from the prior year.
• Amortizatization of Intangibles held at $9.0 million in Q4 2024 per AKBA's latest filing, from $9.0 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $36.0 million in Q4 2021 and troughed at -$24.3 million in Q4 2020.
• A 5-year average of $8.6 million and a median of $9.0 million in 2021 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2020 and 2021: Amortizatization of Intangibles slumped 366.59% in 2020, then jumped 248.51% in 2021.
• A 5-year view of Amortizatization of Intangibles shows it stood at -$24.3 million in 2020, then jumped by 248.51% to $36.0 million in 2021, then sank by 74.99% to $9.0 million in 2022, then fell by 0.01% to $9.0 million in 2023, then increased by 0.36% to $9.0 million in 2024.
• Business Quant data shows AKBA's Amortizatization of Intangibles at $9.0 million in Q4 2024, $9.0 million in Q3 2024, and $9.0 million in Q2 2024.